-

policy paper

PhRMA Comments to the 2020 National Trade Estimate Report

PhRMA’s submission to the Trade Policy Staff Committee of the Executive Office of the President for inclusion in the 2020 National Trade Estimate (NTE) Report outlines the principal trade barriers biopharmaceutical companies face worldwide and identifies concrete actions the U.S. government can take to address these obstacles.